Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $5.12 in the prior trading day, Protara Therapeutics Inc (NASDAQ: TARA) closed at $4.64, down -9.28%. In other words, the price has decreased by -$9.28 from its previous closing price. On the day, 0.53 million shares were traded. TARA stock price reached its highest trading level at $5.03 during the session, while it also had its lowest trading level at $4.43.
Ratios:
Our goal is to gain a better understanding of TARA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.82 and its Current Ratio is at 12.82. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Scotiabank on April 16, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 14 ’25 when Levy Richard S bought 20,000 shares for $3.19 per share. The transaction valued at 63,800 led to the insider holds 51,000 shares of the business.
Zummo Jacqueline sold 21,224 shares of TARA for $96,145 on Mar 26 ’25. The Chf Scientific Operations Off now owns 98,861 shares after completing the transaction at $4.53 per share. On Mar 26 ’25, another insider, Zummo Jacqueline, who serves as the Officer of the company, bought 21,224 shares for $4.55 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TARA now has a Market Capitalization of 179212752 and an Enterprise Value of 60944752.
Stock Price History:
The Beta on a monthly basis for TARA is 1.42, which has changed by 1.0897958 over the last 52 weeks, in comparison to a change of 0.15566266 over the same period for the S&P500. Over the past 52 weeks, TARA has reached a high of $10.48, while it has fallen to a 52-week low of $2.21. The 50-Day Moving Average of the stock is 8.51%, while the 200-Day Moving Average is calculated to be 22.45%.
Shares Statistics:
The stock has traded on average 419.22K shares per day over the past 3-months and 343410 shares per day over the last 10 days, according to various share statistics. A total of 38.58M shares are outstanding, with a floating share count of 33.99M. Insiders hold about 11.89% of the company’s shares, while institutions hold 71.54% stake in the company. Shares short for TARA as of 1760486400 were 2855093 with a Short Ratio of 6.81, compared to 1757894400 on 2691670. Therefore, it implies a Short% of Shares Outstanding of 2855093 and a Short% of Float of 7.59.
Earnings Estimates
The company has 4.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.41, with high estimates of -$0.39 and low estimates of -$0.47.
Analysts are recommending an EPS of between -$1.4 and -$1.58 for the fiscal current year, implying an average EPS of -$1.48. EPS for the following year is -$1.75, with 4.0 analysts recommending between -$1.36 and -$2.2.
